Dolby Laboratories Inc has a consensus price target of $103 based on the ratings of 18 analysis. The 3 most-recent analyst ratings were released by Rosenblatt, Barrington Research, and Rosenblatt on June 7, 2024, June 3, 2024, and May 3, 2024, respectively. With an average price target of $98.67 between Rosenblatt, Barrington Research, and Rosenblatt, there's an implied 25.08% upside for Dolby Laboratories Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/07/2024 | Buy Now | 24.24% | Rosenblatt | Steven Frankel | $98 → $98 | Maintains | Buy | Get Alert |
06/03/2024 | Buy Now | 26.77% | Barrington Research | James Goss | → $100 | Upgrade | Market Perform → Outperform | Get Alert |
05/03/2024 | Buy Now | 24.24% | Rosenblatt | Steve Frankel | $98 → $98 | Maintains | Buy | Get Alert |
04/29/2024 | Buy Now | 24.24% | Rosenblatt | Steve Frankel | $98 → $98 | Maintains | Buy | Get Alert |
01/31/2024 | Buy Now | 24.24% | Rosenblatt | Steve Frankel | → $98 | Reiterates | Buy → Buy | Get Alert |
12/11/2023 | Buy Now | 24.24% | Rosenblatt | Steve Frankel | → $98 | Reiterates | Buy → Buy | Get Alert |
11/17/2023 | Buy Now | 24.24% | Rosenblatt | Steve Frankel | → $98 | Reiterates | Buy → Buy | Get Alert |
08/04/2023 | Buy Now | 24.24% | Rosenblatt | Steve Frankel | $93 → $98 | Maintains | Buy | Get Alert |
07/28/2023 | Buy Now | 17.9% | Rosenblatt | Steve Frankel | → $93 | Reiterates | Buy → Buy | Get Alert |
06/01/2023 | Buy Now | 17.9% | Rosenblatt | Steve Frankel | → $93 | Reiterates | Buy → Buy | Get Alert |
04/26/2023 | Buy Now | 14.1% | Rosenblatt | Steve Frankel | → $90 | Reiterates | → Buy | Get Alert |
04/14/2023 | Buy Now | 47.06% | Tigress Financial | Ivan Feinseth | → $116 | Reiterates | → Buy | Get Alert |
02/03/2023 | Buy Now | 14.1% | Rosenblatt | Steve Frankel | $85 → $90 | Maintains | Buy | Get Alert |
11/18/2022 | Buy Now | — | Barrington Research | James Goss | — | Downgrade | Outperform → Market Perform | Get Alert |
11/07/2022 | Buy Now | 7.76% | Rosenblatt | Steve Frankel | $90 → $85 | Maintains | Buy | Get Alert |
10/14/2022 | Buy Now | 47.06% | Tigress Financial | Ivan Feinseth | $128 → $116 | Maintains | Buy | Get Alert |
05/24/2022 | Buy Now | 14.1% | Rosenblatt | Steve Frankel | → $90 | Initiates | → Buy | Get Alert |
08/02/2021 | Buy Now | 45.79% | Barrington Research | James Goss | — | Upgrade | Market Perform → Outperform | Get Alert |
The latest price target for Dolby Laboratories (NYSE:DLB) was reported by Rosenblatt on June 7, 2024. The analyst firm set a price target for $98.00 expecting DLB to rise to within 12 months (a possible 24.24% upside). 9 analyst firms have reported ratings in the last year.
The latest analyst rating for Dolby Laboratories (NYSE:DLB) was provided by Rosenblatt, and Dolby Laboratories maintained their buy rating.
The last upgrade for Dolby Laboratories Inc happened on June 3, 2024 when Barrington Research raised their price target to $100. Barrington Research previously had a market perform for Dolby Laboratories Inc.
The last downgrade for Dolby Laboratories Inc happened on November 18, 2022 when Barrington Research changed their price target from N/A to N/A for Dolby Laboratories Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dolby Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dolby Laboratories was filed on June 7, 2024 so you should expect the next rating to be made available sometime around June 7, 2025.
While ratings are subjective and will change, the latest Dolby Laboratories (DLB) rating was a maintained with a price target of $98.00 to $98.00. The current price Dolby Laboratories (DLB) is trading at is $78.88, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.